ACEP ID:
Various federal agencies, including the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and the Centers for Medicare & Medicaid Services (CMS), have been continually providing new COVID-19 guidance.
CMS has released the most regulatory guidance. To find more information about all the waivers and flexibilities CMS has granted during the COVID-19 public health emergency, please click here. CMS also continually updates frequently asked questions on these waivers and flexibilities and other Medicare billing issues.
Please click on any of the category cards below to find the latest guidance and government requirements you should be following.
For information on the Provider Relief Fund and other financial relief options, click the Financial Support for Health Care Practitioners category card below.
ACEP will continue to track federal agency announcements and will update this page with information that impact emergency physicians. You can find ACEP's current federal policy priorities here.
In May, ACEP published a detailed summary of the rapid federal and regulatory developments that happened during the initial onslaught of COVID-19. Also, you can read the weekly Regs & Eggs blog for up-to-date information on the key issues that are affecting you and your patients.
EMTALA
Telehealth
HIPAA
Reimbursement
Licensing and Credentialing
Medicaid
MIPS
Financial Support for Health Care Practitioners
Data Collection for Tests
Other Federal Updates & Guidance